COVID-19: Vaccines and Therapeutics
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that puts them at high risk for severe outcomes from the disease. The vaccine also is approved for adults 65 years of age or older.
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention would no longer recommend the COVID-19 vaccine for healthy children and pregnant women.
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England Journal of Medicine.
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services.
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics.
The Centers for Disease Control and Prevention last week endorsed a recommendation from the Advisory Committee on Immunization Practices for people aged 65 and older along with individuals moderately or severely immunocompromised to receive a second dose of the 2024-2025 COVID-19 vaccine six months…
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their patients safe during respiratory virus season.
Autumn is here, and that means cooler weather and also the start of flu season.
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a family member getting a respiratory virus infection this fall and winter.
Vaccines prevent kids from contracting viruses.